Henry Ford Hosp Med Journal
Vol 27, No 2, 1979

Evaluation of a Simplified Measurement for Low Glomerular
Filtration Rates With lndium-111 DTPA
L. E. Preuss, MS,* R. S. Michaels, MD,** F. P. Bolin, MS,* N. W. Levin, MD,* and C. Artman, BS^

A rapid new method for measuring glomerular filtration
rates using " V n diethylenetriamine pentaacetic acid CUnDTPA) was evaluated w i t h 39 patients w h o s h o w e d
marked impairment of renal function (creatinine clearance
less than 20 ml/min). A simple, single compartment system was assumed. For comparison, parallel inulin and
creatinine clearances were performed. High linear correlations (r = 0.96-0.97j were demonstrated when " V n DTPA clearances were compared with the standard nonisotopic tests. Initial data indicate that reliable isotopic
clearance values could be obtained for low clearances by
withdrawing only two blood samples for assay at 6 and 48
hours after isotope injection (without urine assay).

Due to difficulties with accepted techniques for measuring
the glomerular filtration rate (CFR), efforts have concentrated on finding a simple yet accurate method for measuring this renal function.'''^ The accepted standard is the
inulin test, but assays are time consuming and the test is
not routinely used in clinical practice. Clearance of endogenous creatinine is more widely used clinically, but it is
not entirely satisfactory as a measure of very low glomerular filtration rates (CFR less than 20 ml/min). Existing
methods for measuring filtration rates are liable to error in
those cases which are associated with low urinary output,
because of the difficulty of collecting accurate, complete
urine specimens. Hence, a glomerular filtration measurement method independent of urine specimens could be
most useful. In addition to providing information needed
for dialysis schedules, an easily performed measurement
that did not require urine collection would benefit transplant patients or those with urinary fistulae.
Ideally, such a low GFR measurement should: 1) require
only a few samples; 2) avoid urine collection; 3) be administered in a simple, single test.
Numerous attempts have been made to develop a radioactive test for measuring GFR. The substances studied
have included =Tr-EDTA, ^^^Vb-DTPA, and ^^si.jothalmate.^"^ Using a continuous infusion method, Garnett, et
al^ reported excellent correlation between ^^Cr-EDTA and
inulin, while Milutinovic" achieved good results wfth ''^^1iothalmate as compared to inulin in hemodialysis patients
with low GFR. Thus far, however, none of the isotopic
tagged material studied has been entirely accurate nor
capable of establishing a completely linear relationship
wfth inulin over the entire GFR range. Also, most of the
existing studies have not concentrated on the very low
CRF region.
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Formulating a test to measure GFR entails a comparison of
clearance curves to determine optimum sampling intervals, so that little or no information is lost when the
number of assays is reduced.
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Wfth these considerations in mind, a limited study was
designed to collect data for comparing "Mn-DTPA clearances wfth standard inulin and creatinine clearances. At
the same time, the isotope technique was to be evaluated
to determine the minimum number of collection points
needed to obtain an accurate slope for the disappearance
curve.
This inftiai study used "Mn-DTPA to measure GFR. Diethylenetriamine-pentaacetic acid (DTPA) is accepted as a
suitable substance for measuring filtration rates.^'^'^ Its in
vivo stability, which is lacking in such compounds as FeDTPA and Tc Fe-ascorbate, is not significantly decreased
by the
In tag.^ Also, the " In tag has gamma emissions of
173 keV and 247 keV suitable for studies of this type. The
whole-body dose to the patient, primarily from the gamma
emissions, is 48 mRad per 100 /xCi injection. For the
patient with low CFR, the benefits outweigh the risks from
the radiation dosage, providing useful clinical information
in exchange for a modest diagnostic radiation exposure.

trifuged for 15 minutes at 2000 rpm and plasma withdrawn in 0.5 cc volumes. These samples and a standard
volume were then radioassayed on a Searle multisample
gamma counter with analyzer windows set to count both
the 173 keV and 247 keV emissions of
In.
Standard procedures for measuring inulin and creatinine
were used, and isotopic, creatinine, and inulin clearance
values were obtained.^'^
In the usual two-compartment or mamillary^" model for
renal clearance (Figure 1), the injected material disperses
into the primary volume, the blood pool (compartment 1),
which is exchanging with a closed volume (compartment
2) at the same time as it is being lost from compartment 1
into 3, from which no exchange back to 1 is permitted."
Our "Mn-DTPA study used a single injection technique
and a simplified mathematical description of the disappearance process.'^'^^ Data collected by radioactive assay
are converted to net counts/ml and treated graphically to
determine " M n clearance from c o m p a r t m e n t 1. Net
counts/ml are plotted versus actual wfthdrawal times
postlnjection (Figure 2). The real disappearance curve is
complex," as ft is the sum of more than one equilibrium
and exchange process. The last portion of the plot, after
about 60 to 120 minutes, is linear on a semi-log plot; ft
represents the result of isotope disappearance from the
blood pool after equilibrium has been established in the
reservoirs. This linear portion may be extended back to

Methods
For all 39 patients in the study a catheter was inserted into
the antecubital vein and a sample of urine was withdrawn
for background counting. Two background blood samples
were also withdrawn (6-8 cc each). Solutions containing
150-200 ^t.Ci of "Mn-DTPA (a commercial sterile preparation of 500 p,C/m\ activity*) and 50 mg/kg of inulin were
then injected intravenously and the time recorded. After
injection, the venous catheter was attached either to a
heparin lock or to a 5-10 cc syringe of heparin from which
minute amounts were injected to maintain patency for
subsequent blood withdrawals.
After a 45-minute interval to allow for equilibration of the
inulin and the tagged DTPA, blood and urine samples
were collected for inulin, isotope clearance and endogenous creatinine measurements. Following equilibration,
30-minute urine collections were made, from which 6 cc
to 8 cc were obtained for the inulin analysis. For the
isotope measurement, eight additional blood samples of 6
cc were withdrawn beginning one hour postlnjection and
continuing at 2, 4, 8, 12, 24 and 48 hours thereafter. The
exact time of collection was noted for all samples, which
were immediately refrigerated and cold-centrifuged for 15
minutes at 2000 rpm (r=23 cm). Plasma and urine samples were frozen for later standard analysis when radioactivity had reached negligible levels by decay.
When all eight blood samples for radioassay had been
collected over a two-day period, they were cold-cen-
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degree to which these two error factors would compensate for each other, particularly in low GFR subjects.
Should they largely cancel out, then a simple, acceptable
GFR test could result.

Results and Discussion
Thirty-nine patients wfth varied renal function were injected w i t h " M n - D T P A , w h i c h was used to measure
glomerular fiftration rates by measuring the changing isotopic "Mn blood levels. A few subjects wfth GFR greater
than 20 ml/min were included for comparison. These
higher clearances were done with "Mn and compared
wfth simultaneous creatinine values. Simultaneous clearances of efther inulin or creatinine were determined, wfth
29 comparisons made to creatinine and 10 to inulin.
The first 29 sets of data were plotted as "Mn-DTPA versus
creatinine (Figure 3) and the second set of 10 data points
was plotted as "Mn-DTPA versus inulin (Figure 4). The
correlation coefficients for both (0.96 and 0.97, respectively) are sufficiently high to infer a satisfactory linear
relationship between the isotopic and the two nonisotopic
standard methods. In this study, the slope of 1.24 in Figure
3 indicates that "Mn-DTPA clearances, using the above
assumptions, are lower than creatinine GFR values, while

Fig. 2
A plot o f ' " I n - D T P A levels in the blood m (rateof change of concentration
per unit time) is obtained from the slope established in the 4-48 hour
period. Displacement of the t w o plots at 60 and 120 minutes represents
the last phase of the early steep/ slope section of the total disappearance
curve.

the y-axis (by linear regression analysis) to find concentration A^. This concentration is accepted as the blood activity per milliliter that would have existed at time zero, if
dispersal had occurred instantly and been limited exclusively to the vascular system. Use of this zero time value
also assumes that other reservoirs (exchange wfth the
blood pool) are negligible in size or do not carry out rapid
interchange with the blood pool.
Wfth this much simplified mathematical approach,^^ the
clearance was calculated as follows:
rn I
Clearance (ml/min)
Where m = slope of linear regression line (rate of
change of
In plasma concentration)
total injected activity
A_ = activity/ml at time zero (y-intercept value)
These assumptions allow the test to be limited to a simple,
single DTPA administration and a minimum of two plasma
samples, as w i l l be shown. However, as long as compartment 2 and free interchange exist, these assumptions will
result in a plotted disappearance slope that is too shallow
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high side. This pilot study w a s designed to ascertain the

" ' I n - O T P A clearances compared to the creatinine values for 7 subiects.
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TABLE I
Comparison of GFR Values

10
IN-III-DTPA

20
CLEARANCE

30

40

(ml/min)

Fig. 4
Comparison of "Mn-DTPA and inulin clearances. Correlation coefficient
is 0.97. DTPA values on average are greater than those for inulin.

the slope of 0.84 in Figure 4 shows that "Mn-DTPA values
are greater than inulin clearances
Table I lists "Mn-DTPA clearances for 31 subjects calculated in two different ways. Column 2 contains clearance
values obtained using all data points on the 4 to 48 hour
linear portion of the clearance curve, whereas column 3
indicates results using only two of the data points, at
plasma collection times of 4 and about 48 hours. Column
4, which lists the differences in clearance between the 6
and 2 point data, indicates that the absolute differences
are small and consistent for all subjects tested. Moreover,
the coefficient of correlation between the data of column
2 and column 3 is 0.997. The least squares line ofthe allpoint data plotted against the two-point plasma sampling
has a slope of 1.01 and and intercept of - 0 . 0 1 . This
provides strong evidence that the two-specimen method
can accurately determine the slope m (GFR) of the disappearance curve so that additional blood withdrawal is
unnecessary.
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inulin, when measured against inulin as the standard. It is
not surprising that inulin GFRs are not duplicated precisely, since with the simplified theory the equation is an
approximation, lacking a term in the denominator." The
true picture is that of a two-pool mamillary system. With
the second term in the denominator, it is likely that calculated clearances will be higher than true inulin clearances.
Thus, we may conclude that the "Mn-DTPA monitors
clearance as consistently as creatinine does but gives a
closer approximation to inulin values, inulin being the
accepted standard of measurement. The two-plasma sample measurement with "Mn is certainly less liable to the
serious systematic errors inevitably associated with urine
collections and particularly from subjects with very low
filtration rates.
An interesting aspect of the "^ In-DTPA study has been the
consistent production of the straight line disappearance
plot for the 4-48 hour plasma collection. The slope is
precisely and regularly delineated wfth an excellent r and
may be accurately derived from only two plasma samples.
Thus, this rate of change of blood "Mn-DTPA concentration (slope) may be the key to an acceptable, simplified
clearance method for low GFR. This study also drew

The tabular and graphic resufts indicate that GFR determined with "Mn-DTPA linearly follows both inulin and
creatinine and has good correlation in the range of GFR
less than 20 ml/min. In fact, "Mn-DTPA clearance values
are lower than creatinine but higher than inulin. In the
case of low GFR, "Mn-DTPA clearance is more accurate
than creatinine and less accurate (on the high side) than
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blood samples to provide data that would determine the
linear portion of the disappearance curve accurately (see
Figure 1). While six data points were used to determine

patient curves, we found that two data points could be
used without any significant loss of accuracy (Table I).

Conclusion
Our study demonstrated the "Mn-DTPA may be used for
an approximate determination of low GFR clearance,
using a single-injection technique, withdrawal and counting of only two blood samples, as well as a simplified

expression for disappearance. This test could be substituted for routine creatinine clearances in low GFR patients in order to save time and reduce the discomfort of
the patient.
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